Industry marketing payments to physicians and prescription patterns for sacubitril/valsartan in the USA [PDF]
Anju Murayama
openalex +1 more source
Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF. [PDF]
Yang M +18 more
europepmc +1 more source
Cardiorenal safety and efficacy of angiotensin receptor-neprilysin inhibitors in heart failure across the ejection fraction spectrum: A meta-analysis and meta-regression of RCTs with 28,001 patients. [PDF]
Rampengan DDCH +8 more
europepmc +1 more source
The Primary Outcome Is Positive - Is That Good Enough? [PDF]
Pocock, Stuart J, Stone, Gregg W
core +1 more source
Hyperkalemia in Heart Failure with Reduced Ejection Fraction Patients Treated with Sacubitril/Valsartan: Experience from a Tertiary Cardiac Center in Riyadh, Saudi Arabia. [PDF]
Alyousif SM +9 more
europepmc +1 more source
The efficacy and safety of left bundle branch pacing combined with sacubitril/valsartan or enalapril in the treatment of elderly coronary heart disease with chronic heart failure. [PDF]
Zhao C, Zhang H, Zhang J, Chen K.
europepmc +1 more source
Hyperkalaemia szívelégtelenségben. Új kezelési lehetőségek a láthatáron = Hyperkalemia in heart failure. New treatments on the horizon [PDF]
Dékány, Miklós +4 more
core +1 more source
What's new in heart failure? November 2025. [PDF]
Tokcan M +3 more
europepmc +1 more source
The New Era of "Diabetes Prevention, Care and Management": Precision Tools, Predictive Models and New Technologies. [PDF]
Carafa A, Maddaloni E.
europepmc +1 more source
Effects of Cardiac Rehabilitation Exercise Plus Sacubitril Valsartan Sodium on Cardiac Function, Lung Function, and Quality of Life in Patients with Chronic Heart Failure. [PDF]
Li X +5 more
europepmc +1 more source

